Health
Pandemic’s mitigation efforts may have contributed to drop in clinical trial completion rates – News-Medical.Net
Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have…
Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected clinical researchers’ ability to finish trials. Study completion rates dropped worldwide between 13% and 23%, depending on the type of research sponsor and geographic location, between April and October 2020.
Researchers previously reported that more than 80% of clinical trials suspended between March 1 and April 26, 2020, noted…
-
Business16 hours ago3 US dividend stocks that can boost an ASX retirement portfolio
-
Business13 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
General23 hours agoEngland completes sole Ashes warm-up match with flurry of runs to Ollie Pope, Joe Root
-
General21 hours agoDemocratic Republic of Congo and M23 rebel group sign new roadmap to peace in Qatar
